Cargando…

Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer

Immunotherapy is a highly emerging form of breast cancer therapy that enables clinicians to target cancers with specific receptor expression profiles. Two popular immunotherapeutic approaches involve chimeric antigen receptor-T cells (CAR-T) and bispecific antibodies (BsAb). Briefly mentioned in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sivaganesh, Vignesh, Promi, Nazifa, Maher, Salma, Peethambaran, Bela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957700/ https://www.ncbi.nlm.nih.gov/pubmed/33670942 http://dx.doi.org/10.3390/ijms22052433

Ejemplares similares

Protein Tyrosine Phosphatases: Mechanisms in Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets
por: Maher, John, et al.
Publicado: (2023)

Emerging Targets of Immunotherapy in Gynecologic Cancer
por: Cheng, Hongyan, et al.
Publicado: (2020)

Emerging nanomedicines for effective breast cancer immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2020)

Emerging immunotherapy targets in lung cancer
por: Zhu, Hao-Hua, et al.
Publicado: (2020)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Ged, Yasser, et al.
Publicado: (2021)

Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer
por: Gupta, Shradheya R. R., et al.
Publicado: (2023)

Quartet-based inference of cell differentiation trees from ChIP-Seq histone modification data
por: Moumi, Nazifa Ahmed, et al.
Publicado: (2019)

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
por: Mina, Lida A, et al.
Publicado: (2019)

New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020)

New emerging targets in cancer immunotherapy: the role of neoantigens
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2020)

New emerging targets in cancer immunotherapy: the role of GITR
por: Buzzatti, Giulia, et al.
Publicado: (2020)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
por: Liu, Tongyan, et al.
Publicado: (2019)

Immunotherapies against HER2-Positive Breast Cancer
por: Duro-Sánchez, Santiago, et al.
Publicado: (2023)

Novel technologies and emerging biomarkers for personalized cancer immunotherapy
por: Yuan, Jianda, et al.
Publicado: (2016)

Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics
por: Baccili Cury Megid, Thais, et al.
Publicado: (2023)

Metabolic checkpoints and novel approaches for immunotherapy against cancer
por: Li, Yiming, et al.
Publicado: (2021)

New emerging targets in cancer immunotherapy: the role of TIM3
por: Friedlaender, Alex, et al.
Publicado: (2019)

New emerging targets in cancer immunotherapy: the role of LAG3
por: Puhr, Hannah Christina, et al.
Publicado: (2019)

Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy
por: Bou-Dargham, Mayassa J., et al.
Publicado: (2021)

Targeting Both Autophagy and Immunotherapy in Breast Cancer Treatment
por: Giannopoulos, Spyridon, et al.
Publicado: (2022)

Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
por: Koch, Regina M., et al.
Publicado: (2021)

Current and Emerging Targets in Immunotherapy for Osteosarcoma
por: Miwa, Shinji, et al.
Publicado: (2019)

Novel targets for immunotherapy in glomerulonephritis
por: Foster, Mary H
Publicado: (2008)

Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

Targeting CD47 as a Novel Immunotherapy for Breast Cancer
por: Chen, Can, et al.
Publicado: (2022)

ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
por: Fultang, Norman, et al.
Publicado: (2020)

Novel targeted therapies and immunotherapy for advanced thyroid cancers
por: Naoum, George E., et al.
Publicado: (2018)

CD24: A Novel Target for Cancer Immunotherapy
por: Panagiotou, Emmanouil, et al.
Publicado: (2022)

Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy
por: Cao, Weijie, et al.
Publicado: (2022)

Recent advances in immunotherapy and molecular targeted therapy for gastric cancer
por: Yoshinami, Yuri, et al.
Publicado: (2023)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Starzer, Angelika M., et al.
Publicado: (2020)

Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
por: Wang, Yi, et al.
Publicado: (2022)

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
por: Ye, Feng, et al.
Publicado: (2023)

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
por: Fultang, Norman, et al.
Publicado: (2019)

Emerging Trends in Immunotherapy for Cancer
por: Mishra, Alok K., et al.
Publicado: (2022)

Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages
por: Reis-Sobreiro, Mariana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gimch9msslp54mq24e3i58fc6m